Moderna Could Face Patent Infringement Lawsuit Over Covid-19 Vaccine
The court upheld the US Patent Trial and Appeal Board’s findings that Arbutus’ patents are valid as the science involved was previously unknown. Arbutus’ patents may cover technology used in the Covid-19 vaccine.
In court filings, Moderna had previously stated that it believes that, if the patents were upheld, Arbutus could launch a lawsuit…
Read More...